Nanopharm-logo-with-signature-Pantone (1)

News & Events

Nanopharm News & Events

Nanopharm is continually expanding its specialized nasal and inhaled drug delivery development capabilities and participates in numerous events within the OINDP pharmaceutical community. Learn more about the latest news and events at Nanopharm.

18 July 2025

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

The acquisition of Mod3 Pharma’s clinical trial materials manufacturing capabilities strengthens Aptar Pharma’s service portfolio to meet growing demand for early-phase clinical trial support and innovation.

Press Release

Filter Resources By

Filters
Filters
Type
Topic
Show (31)
Cancel
The acquisition of Mod3 Pharma’s clinical trial materials manufacturing capabilities strengthens Aptar Pharma’s service portfolio to meet growing demand for early-phase clinical trial support and innovation

18 Jul 2025

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

Innovation & Insights

Blue gradient background with a small letter I in a circle in the background with white News & Events text.

06 Dec 2024

Nanopharm Newsletter November 2024

Nanopharm, Newsletter, OINDPs

19 Apr 2024

Nanopharm Announces Exclusive Collaboration With Fluidda To Accelerate Regulatory Pathway For OINDP Using SmartTrack

Innovation & Insights

19 Apr 2024

Nanopharm & FLUIDDA Interviews on SmartTrack: In Vitro-In Silico Approaches for Demonstrating Bioequivalence for OINDP

Innovation & Insights

Round blue Nanopharm SmartTrack infographic showing 5 key parts of the in-silico in-vitro modelling platform at Nanopharm.

17 Apr 2024

A Holistic Demonstration of SmartTrack™ and New Ways of Collaborating Combine for a Successful FDA Workshop

Innovation & Insights

01 Jun 2023

Optimising batch selection to increase success of PK studies for bioequivalence

bioequivalence, Nanopharm, OINDP, PBPK modelling, Pharmacokinetic, SmartTrack

01 Dec 2022

Alternative Regulatory Pathway for Generic Inhaled Drugs

Drug Product, Generic, Inhalation, OINDP, Pharmaceutical regulatory

01 Oct 2022

Physiologically-based Pharmacokinetic Models (PBPK) for OINDPs

Aptar Pharma, OINDP, PBPK, PBPK models

11 May 2022

Why it is time to ‘Think Different’ about nasal delivery of biologics.

Biologics, COVID-19, Nasal, Nasal Delivery, therapeutics

15 Apr 2022

Nasal Drug Development, Trends and Challenges with Nasal Formulations

drug formulation, formulation and development, Nasal

14 Apr 2022

Nanopharm’s Innovations in Nasal Drug Delivery of Biologics

Biologics, drug delivery, Drug Development, Nanopharm, Nasal, SARS-CoV-2

06 Apr 2022

Investigating The Propellant Pathways Leading To a Sustainable Future of MDIs

environmental footprint, Global Warming Potential, MDIs, metered dose inhalers, SmartTrack

  CONTACT
+44 (0) 1633 372200
info@nanopharm.co.uk

Nanopharm Ltd
Franklin House, Grange Road, Cwmbran, NP44 3WY, United Kingdom   

STAY CONNECTED

Linkedin Youtube
General Terms and Conditions of Use and Privacy Policy
Terms & Conditions of Sales

© 2024. Nanopharm Ltd. All rights reserved.